202 related articles for article (PubMed ID: 3979390)
1. Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitution.
Southan C; Lane DA; Bode W; Henschen A
Eur J Biochem; 1985 Mar; 147(3):593-600. PubMed ID: 3979390
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
Ebert RF; Schreiler WE; Bell WR
Thromb Res; 1986 Jul; 43(1):7-13. PubMed ID: 3726812
[TBL] [Abstract][Full Text] [Related]
3. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A
Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
[TBL] [Abstract][Full Text] [Related]
4. Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin.
Higgins DL; Lewis SD; Shafer JA
J Biol Chem; 1983 Aug; 258(15):9276-82. PubMed ID: 6409903
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules.
Siebenlist KR; Prchal JT; Mosesson MW
Blood; 1988 Mar; 71(3):613-8. PubMed ID: 3345340
[TBL] [Abstract][Full Text] [Related]
6. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).
Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G
Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644
[TBL] [Abstract][Full Text] [Related]
8. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
Rooney MM; Mullin JL; Lord ST
Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G
Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451
[TBL] [Abstract][Full Text] [Related]
10. Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release.
Mullin JL; Gorkun OV; Binnie CG; Lord ST
J Biol Chem; 2000 Aug; 275(33):25239-46. PubMed ID: 10837485
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.
Lee MH; Kaczmarek E; Chin DT; Oda A; McIntosh S; Bauer KA; Clyne LP; McDonagh J
Blood; 1991 Oct; 78(7):1744-52. PubMed ID: 1912564
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution.
Borrell M; Vila L; Solá J; Coll I; Fontcuberta J
Haemostasis; 1990; 20(1):1-7. PubMed ID: 2323678
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration.
Profumo A; Turci M; Damonte G; Ferri F; Magatti D; Cardinali B; Cuniberti C; Rocco M
Biochemistry; 2003 Oct; 42(42):12335-48. PubMed ID: 14567695
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Manchester: identification of an abnormal fibrinopeptide A with a C-terminal arginine leads to histidine substitution.
Southan C; Kehl M; Henschen A; Lane DA
Br J Haematol; 1983 May; 54(1):143-51. PubMed ID: 6849832
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen Sapporo: dysfibrinogenemia characterized by the replacement of A alpha arginine-16 by histidine resulting in the delayed release of fibrinopeptide A by thrombin.
Asakura S; Terukina S; Yamazumi K; Matsuda M; Murayama H; Higuchi A; Musashi M; Sakurada K; Miyazaki T
Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1094-104. PubMed ID: 2588959
[TBL] [Abstract][Full Text] [Related]
16. Novel structure elucidation strategy for genetically abnormal fibrinogens with incomplete fibrinopeptide release as applied to fibrinogen Schwarzach.
Henschen A; Kehl M; Deutsch E
Hoppe Seylers Z Physiol Chem; 1983 Dec; 364(12):1747-51. PubMed ID: 6667926
[TBL] [Abstract][Full Text] [Related]
17. [Fibrinogen Bern II: hereditary fibrinogen variant with amino acid substitution of arginine replaced by histidine in position 16 of the A alpha chain].
Rupp C; Sievi R; Furlan M; Beck EA
Schweiz Med Wochenschr; 1983 Oct; 113(40):1460-2. PubMed ID: 6648427
[TBL] [Abstract][Full Text] [Related]
18. A thrombin assay based upon the release of fibrinopeptide A from fibrinogen: definition of a new thrombin unit.
Lewis SD; Shafer JA
Thromb Res; 1984 Jul; 35(2):111-20. PubMed ID: 6474412
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M
Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828
[TBL] [Abstract][Full Text] [Related]
20. Kinetic aspects of release of fibrinopeptides AP and AY by human alpha-thrombin.
De Cristofaro R; Castagnola M
Haemostasis; 1991; 21(2):85-90. PubMed ID: 1959802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]